UVDDB p127-binding modulates activities and intracellular distribution of Hepatitis B virus X protein
- 7 September 2000
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 19 (38), 4417-4426
- https://doi.org/10.1038/sj.onc.1203771
Abstract
Mammalian hepatitis B viruses encode a unique regulatory protein termed X, which is essential for infection and likely plays a role in the carcinogenic process associated with hepadnaviral infection. Among the numerous properties ascribed to X protein, two have been widely documented: promiscuous transcriptional transactivation and proapoptosis. However, full understanding of the mechanisms underlying these activities requires the identification of the genuine X partners among the multiple X-binding host proteins. Here we show that (i) mutations in X protein, which markedly alter affinity for the host protein UVDDBp127, inactivate both transactivation and proapoptosis; (ii) ectopic fusion of a functional UVDDB-binding domain to a deficient binding X mutant restored its activity; (iii) in contrast to the loss-of-binding mutants, a mutant with a strong gain-of-binding exerted trans-dominant negative effects on wt X activity and localized in the nucleus and (iv) increase in intracellular UVDDB concentration enhanced both wt X-mediated transactivation and apoptosis. Taken together, our data provide strong evidence for a common upstream step in X mode of action, consisting of its productive interaction with UVDDB, via a structurally and functionally autonomous module. In addition, they underscore a nuclear location step of the viral protein that depends on its ability to bind UVDDB.Keywords
This publication has 30 references indexed in Scilit:
- Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B virusesOncogene, 2000
- The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell linesOncogene, 1999
- Characterization of IκBα Nuclear Import PathwayPublished by Elsevier BV ,1999
- Status of hepatitis B immunization programmes in 1998Vaccine, 1998
- Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomasHepatology, 1998
- Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathwayNature, 1993
- Purification and characterization of a human protein that binds to damaged DNABiochemistry, 1993
- Randomization of genes by PCR mutagenesis.Genome Research, 1992
- Hepatitis B virus X‐gene product: A promiscuous transcriptional activatorJournal of Medical Virology, 1992
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981